Fluorescein Angiography Market Size, Share, Trends, Growth Outlook

Fluorescein Angiography Market is estimated to increase at a growth rate of 4.9% CAGR over the forecast period from 2024 to 2030.

 

The Fluorescein Angiography Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Device, Disposables, Accessories), By Technology (Digital, Analog), By Application (Macular edema, Macular degeneration, Macular pucker, Ocular melanoma, Diabetic retinopathy, Others).

 

An Introduction to Fluorescein Angiography Market in 2024

The fluorescein angiography market in 2024 serves the demand for diagnostic imaging procedures and contrast agents used in ophthalmology and retinal imaging to visualize the blood flow and vascular structures of the retina and choroid, aiding in the diagnosis and management of various retinal diseases and ocular conditions such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vascular occlusions. Fluorescein angiography involves the intravenous injection of fluorescein dye, followed by sequential retinal imaging with specialized fundus cameras equipped with blue light filters and excitation wavelengths to capture the fluorescence of the dye within retinal blood vessels and capillaries. Market dynamics are driven by factors such as the increasing prevalence of retinal disorders and vision-threatening diseases, the growing demand for early disease detection and treatment monitoring, and advancements in digital imaging technology, dye formulation, and image analysis software for high-resolution angiographic imaging and quantitative analysis. Collaboration between fluorescein angiography equipment manufacturers, ophthalmologists, and retina specialists drives innovation and market expansion in fluorescein angiography, supporting better retinal diagnostics, treatment planning, and visual outcomes for patients with retinal pathology and ocular diseases.

Fluorescein Angiography Market Trend: Adoption of Digital Fluorescein Angiography Systems

A significant trend in the Fluorescein Angiography market is the increasing adoption of digital fluorescein angiography (FA) systems. Digital FA systems offer several advantages over traditional film-based systems, including real-time image acquisition, enhanced image quality, and the ability to store, retrieve, and analyze images digitally. Healthcare facilities are transitioning to digital FA systems to improve workflow efficiency, facilitate remote image interpretation, and integrate FA images into electronic health records (EHRs), driving market growth.

Fluorescein Angiography Market Driver: Rising Incidence of Retinal Diseases and Disorders

A key driver in the Fluorescein Angiography market is the rising incidence of retinal diseases and disorders, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vascular occlusions. These conditions often require fluorescein angiography as a diagnostic tool to assess retinal blood flow, detect abnormalities, and guide treatment decisions. With the growing prevalence of retinal diseases globally, there is an increasing demand for fluorescein angiography procedures, fueling market expansion.

Fluorescein Angiography Market Opportunity: Development of Non-invasive Imaging Techniques

An opportunity for innovation in the Fluorescein Angiography market lies in the development of non-invasive imaging techniques for retinal evaluation. While fluorescein angiography is highly effective for visualizing retinal vasculature and pathology, it requires the intravenous injection of fluorescein dye, which can be associated with certain risks and discomfort for patients. Manufacturers can explore the development of non-invasive imaging modalities, such as optical coherence tomography angiography (OCTA), that offer detailed visualization of retinal blood flow and microvasculature without the need for dye injection. By addressing patient concerns and enhancing procedural safety and comfort, non-invasive imaging technologies have the potential to expand the market reach of retinal imaging diagnostics.

 

Fluorescein Angiography Market Segmentation

By Product

Device

Disposables

-Dye

-Film

Accessories

 

By Technology

Digital

Analog

 

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Fluorescein Angiography Market Companies

Canon Inc

Carl Zeiss Meditec Inc

CenterVue SpA

Heidelberg Engineering GmbH

Kowa Company Ltd

NIDEK Co. Ltd

Optomed Oy Ltd

Topcon Corp

*- List Not Exhaustive

 

Reasons to Buy the Fluorescein Angiography Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Fluorescein Angiography Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Fluorescein Angiography Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Fluorescein Angiography Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Fluorescein Angiography Market Size Outlook, $ Million, 2021 to 2030

3.2 Fluorescein Angiography Market Outlook by Type, $ Million, 2021 to 2030

3.3 Fluorescein Angiography Market Outlook by Product, $ Million, 2021 to 2030

3.4 Fluorescein Angiography Market Outlook by Application, $ Million, 2021 to 2030

3.5 Fluorescein Angiography Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Fluorescein Angiography Market Industry

4.2 Key Market Trends in Fluorescein Angiography Market Industry

4.3 Potential Opportunities in Fluorescein Angiography Market Industry

4.4 Key Challenges in Fluorescein Angiography Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Fluorescein Angiography Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Fluorescein Angiography Market Outlook By Segments

7.1 Fluorescein Angiography Market Outlook by Segments

By Product

Device

Disposables

-Dye

-Film

Accessories

By Technology

Digital

Analog

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

8 North America Fluorescein Angiography Market Analysis And Outlook To 2030

8.1 Introduction to North America Fluorescein Angiography Markets in 2024

8.2 North America Fluorescein Angiography Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Fluorescein Angiography Market size Outlook by Segments, 2021-2030

By Product

Device

Disposables

-Dye

-Film

Accessories

By Technology

Digital

Analog

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

9 Europe Fluorescein Angiography Market Analysis And Outlook To 2030

9.1 Introduction to Europe Fluorescein Angiography Markets in 2024

9.2 Europe Fluorescein Angiography Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Fluorescein Angiography Market Size Outlook By Segments, 2021-2030

By Product

Device

Disposables

-Dye

-Film

Accessories

By Technology

Digital

Analog

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

10 Asia Pacific Fluorescein Angiography Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Fluorescein Angiography Markets in 2024

10.2 Asia Pacific Fluorescein Angiography Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Fluorescein Angiography Market size Outlook by Segments, 2021-2030

By Product

Device

Disposables

-Dye

-Film

Accessories

By Technology

Digital

Analog

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

11 South America Fluorescein Angiography Market Analysis And Outlook To 2030

11.1 Introduction to South America Fluorescein Angiography Markets in 2024

11.2 South America Fluorescein Angiography Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Fluorescein Angiography Market size Outlook by Segments, 2021-2030

By Product

Device

Disposables

-Dye

-Film

Accessories

By Technology

Digital

Analog

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

12 Middle East And Africa Fluorescein Angiography Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Fluorescein Angiography Markets in 2024

12.2 Middle East and Africa Fluorescein Angiography Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Fluorescein Angiography Market size Outlook by Segments, 2021-2030

By Product

Device

Disposables

-Dye

-Film

Accessories

By Technology

Digital

Analog

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Canon Inc

Carl Zeiss Meditec Inc

CenterVue SpA

Heidelberg Engineering GmbH

Kowa Company Ltd

NIDEK Co. Ltd

Optomed Oy Ltd

Topcon Corp

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Fluorescein Angiography Market Segmentation

By Product

Device

Disposables

-Dye

-Film

Accessories

 

By Technology

Digital

Analog

 

By Application

Macular edema

Macular degeneration

Macular pucker

Ocular melanoma

Diabetic retinopathy

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)